VIKING GLOBAL INVESTORS LP 13D and 13G filings for BioMarin Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:53 pm Sale | 2025-09-30 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VIKING GLOBAL INVESTORS LP | 8,322,179 4.300% | -3,966,432 (-32.28%) | Filing |
| 2025-08-14 5:32 pm Purchase | 2025-06-30 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VIKING GLOBAL INVESTORS LP | 12,288,611 6.400% | 2,535,318 (+25.99%) | Filing |
| 2024-09-30 4:29 pm Purchase | 2024-09-20 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VIKING GLOBAL INVESTORS LP | 9,753,293 5.100% | 9,753,293 (New Position) | Filing |